wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q34983601-6E63E4A4-FEED-4E70-A2A0-244BA7CBDD00
Q34983601-6E63E4A4-FEED-4E70-A2A0-244BA7CBDD00
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34983601-6E63E4A4-FEED-4E70-A2A0-244BA7CBDD00
Phase II, multicenter, open-label, randomized study of YM155 plus docetaxel as first-line treatment in patients with HER2-negative metastatic breast cancer.
P2860
Q34983601-6E63E4A4-FEED-4E70-A2A0-244BA7CBDD00
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34983601-6E63E4A4-FEED-4E70-A2A0-244BA7CBDD00
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
74e1ecb2e7d2b89b45fc3f361005c14a0cc45860
P2860
YM155, a novel small-molecule survivin suppressant, induces regression of established human hormone-refractory prostate tumor xenografts.